- 专利标题： METHODS FOR PREDICTING IMMUNE CHECKPOINT BLOCKADE EFFICACY ACROSS MULTIPLE CANCER TYPES
-
申请号： US18571085申请日： 2022-06-17
-
公开(公告)号： US20240282410A1公开(公告)日： 2024-08-22
- 发明人: Luc Morris , Timothy Chan , Diego Chowell , Cristina Valero , Nils Weinhold , Seong-Keun Yoo
- 申请人： Memorial Sloan-Kettering Cancer Center , Memorial Hospital for Cancer and Allied Diseases , Sloan-Kettering Institute for Cancer Research , Cleveland Clinic Foundation
- 申请人地址： US NY New York
- 专利权人： Memorial Sloan-Kettering Cancer Center,Memorial Hospital for Cancer and Allied Diseases,Sloan-Kettering Institute for Cancer Research,Cleveland Clinic Foundation
- 当前专利权人： Memorial Sloan-Kettering Cancer Center,Memorial Hospital for Cancer and Allied Diseases,Sloan-Kettering Institute for Cancer Research,Cleveland Clinic Foundation
- 当前专利权人地址： US NY New York
- 国际申请： PCT/US22/33978 2022.06.17
- 进入国家日期： 2023-12-15
- 主分类号： G16B40/20
- IPC分类号： G16B40/20 ; G16B20/00 ; G16H20/17 ; G16H50/70
摘要：
The present disclosure relates generally to methods, devices, and systems for accurately predicting the efficacy of immune checkpoint blockade therapy across multiple cancer types.
信息查询
